Skip to main content
. 2015 Mar 13;125(18):2779–2785. doi: 10.1182/blood-2014-12-613570

Table 4.

End-of-treatment overall response rate

Patients, n (%) G-FC (n = 21) G-B (n = 20)
ORR (CR + CRi + PR) 13 (62) 18 (90)
 CR 2 (10) 4 (20)
 CRi 3 (14) 5 (25)
 PR 8 (38) 9 (45)
SD 4 (19) 0
PD 0 0
Not evaluable* 1 (5) 1 (5)
Missing 3 (14) 1 (5)

PD, progressive disease; PR, partial response; SD, stable disease.

*

Not evaluable. G-FC (n = 1) and G-B (n = 1): end-of-treatment CT not evaluable.

Missing. G-FC: response assessed too early (n = 1); early treatment discontinuation due to adverse event (n = 2). G-B: response assessed too early (n = 1).